Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Alfimeprase: Additional Phase III data

NUVO disclosed additional data from the double-blind, placebo-controlled Phase III SONOMA-2 trial in 303 patients that showed catheter function was restored

Read the full 212 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE